Durvalumab vs Vecuronium Bromide

Durvalumab vs Vecuronium Bromide: Overview

This comparison examines the pharmacological differences between Durvalumab and Vecuronium Bromide.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Durvalumab — 17 days.

Chemical Properties

Type: Durvalumab — Antibody; Vecuronium Bromide — Small molecule.